Pay in 4 interest-free payments of $5.85 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Regulatory Status and Safety Concerns BPC-157 is not approved for clinical use by any major health authority worldwide: U.S
In the UK, BPC-157 has no MHRA marketing authorisation, so any sale or supply for human therapeutic use falls into the category of unlicensed medicine and sits outside standard legal and professional frameworks
Target stubborn fat areas Peptides are believed to interact with the specific receptors (alpha-2 receptors) that are located in the stubborn fat areas, such as the abdomen and thighs
Reviewed by Jarred Mait, MD Peptide-based therapies are increasingly discussed in regenerative medicine settings, particularly among patients seeking non-surgical options for injury recovery and tissue support
US$ 26.25
US$ 23.13
US$ 21.46
